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General Information.  Commercial reagents were purified prior to use following the
guidelines of Perrin and Armarego.1  Non-aqueous reagents were transferred under nitrogen via
syringe or cannula.  Organic solutions were concentrated under reduced pressure on a Büchi
rotary evaporator.  Chromatographic purification of products was accomplished using forced-
flow chromatography on ICN 60 32-64 mesh silica gel 63 according to the method of Still.2
Thin-layer chromatography (TLC) was performed on EM Reagents 0.25 mm silica gel 60-F
plates.  Visualization of the developed chromatogram was performed by fluorescence quenching
or by KMnO4 stain.
1H and 13C NMR spectra were recorded on a Mercury 300 (300 MHz and 75 MHz) as
noted, and are internally referenced to residual protio solvent signals.  Data for 1H NMR are
reported as follows: chemical shift (δ ppm), multiplicity (s = singlet, d = doublet, t = triplet, q =
quartet, m = multiplet), integration, coupling constant (Hz) and assignment.  Data for 13C NMR
are reported in terms of chemical shift.  IR spectra were recorded on a Perkin Elmer Paragon
1000 spectrometer and are reported in terms of frequency of absorption (cm-1).  Mass spectra
were obtained from the UC Irvine Mass Spectral facility.  Gas liquid chromatography (GLC) was
performed on Hewlett-Packard 6850 and 6890 Series gas chromatographs equipped with a split-
mode capillary injection system and flame ionization detectors using a Bodman Chiraldex β-DM
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(30 m x 0.25 mm) column.  High performance liquid chromatography (HPLC) was performed on
Hewlett-Packard 1100 Series chromatographs using either a Chiralcel OD-H column (25 cm) and
OD guard (5 cm) or a Chiralcel AD column (25 cm) and AD guard (5 cm) as noted.
The α,β-unstaurated ketones: 3-penten-2-one,3 4-octen-3-one,4 6-methylhept-4-en-3-one,5
2-methylhex-4-en-3-one,6 6-methylhept-2-en-4-one;7 dienes: buta-1,3-dienyl-carbamic acid
benzyl ester,8 1-(methyleneallyl)-benzene;9 and (5S)-5-benzyl-3-methyl-imidazolidin-4-one10
were prepared as described in the literature.
(2R, 5R)-3-Methyl-2,5-diphenyl-imidazolidin-4-one (catalyst 3).  A solution of (R)-
phenylglycine methyl amide11 (2.0 g, 12.2 mmol), benzaldehyde (990 µL, 9.7 mmol), and p-
toluenesulfonic acid monohydrate (232 mg, 1.2 mmol) dissolved in 20 mL of methanol was
heated to reflux for 16 hours.  Concentration of the reaction mixture followed by silica gel
chromatography (30-40% ethyl acetate in hexanes, linear gradient) afforded the title compound
in 31% yield (750 mg, 3.0 mmol) and the more quickly eluting (2S, 5R) isomer in 58% yield
(1.43g, 5.7 mmol).  IR (film) 3478, 3324, 3086, 3063, 3031, 2958, 2917, 2863, 1959, 1890,
1814, 1698, 1603, 1477, 1456, 1428, 1400, 1343, 1281, 1204, 1107, 1069, 1027, 985.9, 935.2,
916.7, 868.6, 834.7, 732.9, 698.1 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.41 (m, 10H, ArH), 5.33
(s, 1H, NCHN), 4.66 (s, 1H, CHCO), 2.65 (s, 3H, CH3), 2.46 (s, 1H, NH); 13C NMR (75 MHz,
CDCl3) δ 173.4, 139.0, 138.6, 129.8, 129.3, 128.9, 128.3, 128.0, 127.7, 77.3, 63.7, 28.0; HRMS
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(CI) exact mass calc’d for (C16H16N2O) requires m/z 252.1263, found m/z 252.1265. [α]D = - 8.6
(c = 1.0, CHCl3).  The relative stereochemistry of catalyst 3 was confirmed by nOe studies.
(2S, 5S)-5-Benzyl-3-methyl-2-phenyl-imidazolidin-4-one (catalyst 4).  A solution of
(S)-phenylalanine methyl amide (5.0 g, 28.1 mmol), benzaldehyde (3.14 mL, 30.9 mmol), and p-
toluenesulfonic acid monohydrate (535 mg, 2.8 mmol) dissolved in 40 mL of methanol was
heated to 50 °C for 24 hours.  Concentration of the reaction mixture followed by silica gel
chromatography (3:1 ethyl acetate:hexanes) afforded the title compound in 32% yield (2.38 g,
8.9 mmol) and the more quickly eluting (2R, 5S) isomer in 58% yield (4.32 g, 16.2 mmol).  IR
(film) 3479, 3331, 3085, 3061, 3030, 2921, 2861, 2242, 1959, 1891, 1815, 1696, 1603, 1494,
1475, 1436, 1370, 1335, 1282, 1206, 1098, 1028, 1002, 920.0, 760.0, 743.2, 700.7 cm-1; 1H
NMR (300 MHz, CDCl3) δ 7.25 (m, 8H, ArH), 6.82 (m, 2H, ArH), 5.10 (m, 1H, NCHN), 3.84
(dd, J = 4.5, 4.5 Hz, 1H, CHCO), 3.22 (dd, J = 14.1, 5.7 Hz, 1H, one of CH2Ph), 3.11 (dd, J =
14.1, 4.5 Hz, 1H, one of CH2Ph), 2.52 (s, 3H, CH3), 1.87 (br s, 1H, NH); 13C NMR (75 MHz,
CDCl3) δ 174.6, 138.8, 137.1, 130.1, 129.7, 129.2, 129.1, 127.4, 127.1, 60.7, 37.2, 27.5; HRMS
(CI) exact mass calc’d for (C17H18N2O) requires m/z 266.1419, found m/z 266.1421. [α]D = -
101.8 (c = 1.0, CHCl3).  The enantiopurity of the catalyst was confirmed (>99% ee) by HPLC
analysis (AD column, 10% isopropanol in hexanes, 1 mL/min, 254 nm); (2S, 5S) isomer tr = 17.1
min, (2R, 5R) isomer tr = 15.5 min.  The relative stereochemistry of catalyst 4 was confirmed by
nOe studies.  It should be noted that longer reaction times, higher temperatures, or an excess of
benzaldehyde can lead to significant racemization of the catalyst.12
(2S, 5S)-5-Benzyl-3-methyl-2-(5-methyl-furan-2-yl)-imidazolidin-4-one  (catalyst 5).
In an inert atmosphere glovebox, samarium (III) trifluoromethanesulfonate (1.20 g, 2.0 mmol)
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was added to a flame-dried 250 mL 3-neck round bottom flask fitted with a glass stopper, a
septum, and a vacuum hose adapter followed by powdered 4Å molecular sieves (4.0 g).
Following removal from the glove-box, the reaction was placed under nitrogen and (S)-
phenylalanine methyl amide (8.91 g, 50 mmol) was added as a solution in 80 mL of
tetrahydrofuran immediately followed by freshly distilled (77 oC, 14 mmHg, Vigreaux collumn)
clear, colorless 5-methylfurfural (3.98 mL, 40 mmol).  After stirring for 29 hours at room
temperature, the reaction mixture was filtered through a plug of silica with dichloromethane,
concentrated and purified by silica gel chromatography (1:1 ethyl acetate:hexanes) to afford the
title compound as a clear, colorless oil in 46% yield (4.93 g, 18.2 mmol) and the faster eluting
(2R, 5S) isomer as a pale yellow oil in 38% yield (4.10 g, 15.2 mmol).  IR (film) 3482, 3325,
2922, 2862, 1695, 1563, 1495, 1477, 1453, 1402, 1326, 1267, 1218, 1098, 1021, 1006, 956.8,
938.9, 791.1, 734.4, 701.5 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.26 (m, 5H, PhH), 6.11 (m, 1H,
CHCHCCH3), 5.89 (m, 1H, CHCHCCH3 ), 5.19 (s, 1H, NCHN), 3.79 (dd, J = 7.2, 4.5 Hz, 1H,
CHCONMe), 3.26 (dd, J = 14.4, 4.5 Hz, 1H, one of CH2Ph), 3.09 (dd, J = 14.1, 7.5 Hz, 1H, one
of CH2Ph), 2.64 (s, 3H, NCH3), 2.21 (s, 3H, ArCH3), 2.10 (br s, 1H, NH); 13C NMR (75 MHz,
CDCl3) δ 173.9, 153.5, 148.5, 137.3, 129.6, 128.9, 127.0, 111.2, 106.6, 71.3, 60.5, 37.8, 27.4,
14.0; HRMS (CI) exact mass calc’d for (C16H18N2O2) requires m/z 270.1368, found m/z
270.1368. [α]D = – 156.5 (c = 1.0, CHCl3).  The enantiopurity of the catalyst was confirmed
(>99% ee) by HPLC analysis (AD column, 5% isopropanol in hexanes, 1 mL/min, 254 nm); (2S,
5S) isomer tr = 22.9 min, (2R, 5R) isomer tr = 25.7 min.  The relative stereochemistry of catalyst
5 was confirmed by nOe studies.
General Procedure (A: propenyl ketones):  A 10-ml roundbottomed flask equipped
with a magnetic stir bar and containing (2S, 5S)-5-benzyl-3-methyl-2-(5-methyl-furan-2-yl)-
imidazolidin-4-one (5) (0.2 eq.) was either charged with H2O (3-7M) or no solvent and cooled to
0 °C.  To the resulting suspension was added the α,β-unsaturated ketone (1.0 eq.) followed by
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70% aqueous perchloric acid (0.2 eq.).  After stirring for 5 minutes, freshly distilled, pre-chilled
cyclopentadiene (1.5 eq.) was added dropwise.  The resulting biphasic mixture was stirred at
constant temperature until complete consumption of the α,β-unsaturated ketone was observed as
determined by TLC or GLC analysis.  The reaction mixture was then diluted with the appropriate
eluent, and then purified directly by silica gel chromatography.
General Procedure (B: ethyl vinyl ketone):  (2S, 5S)-5-Benzyl-3-methyl-2-(5-methyl-
furan-2-yl)-imidazolidin-4-one (5) was taken up in absolute ethanol (1-2M) and cooled to the
appropriate temperature (–20 to –40 °C) with stirring.  Ethyl vinyl ketone (1.0 eq.) was added to
that chilled solution, followed by dropwise addition of 70% aqueous perchloric acid down the
side of the flask.  After stirring for 5 minutes, the diene (1.25-1.5 eq.) was added and the
resulting solution was stirred at constant temperature until complete consumption of the α,β-
unsaturated ketone was observed as determined by TLC or GLC analysis.  The reaction mixture
was then diluted with the appropriate eluent, and then purified directly by silica gel
chromatography.
1-[(1R , 2R, 3S, 4R)-3-Methylbicyclo[2.2.1]hept-5-en-2-yl]-ethanone (Table 2, entry
1).  Prepared according to general procedure A from 3-penten-2-one (68 µL, 0.70 mmol),
cyclopentadiene (69 µL, 0.84 mmol), 70% aqueous perchloric acid (12.1 µL, 0.14 mmol) and
(2S, 5S)-5-benzyl-3-methyl-2-(5-methyl-furan-2-yl)-imidazolidin-4-one (37.8 mg, 0.14 mmol) in
water (175 µL) for 2.5 hours at 0 °C.  Purification by silica gel chromatography (9:1
pentane:ether) provided the title compound as a colorless oil in 85% yield (89 mg, 0.59 mmol);
14:1 endo:exo, endo 61% ee. IR (film) 3061, 2962, 2871, 1708, 1461, 1426, 1359, 1333, 1267,
1183, 1170, 114, 1095, 1055, 906.8, 797.8, 719.4, 654.5, 597.0 cm-1; 1H NMR (300 MHz,
CDCl3) δ 6.21 (dd, J = 6.0, 3.3 Hz, 1H, CH=CH), 5.90 (dd, J = 5.7, 2.7 Hz, 1H, CH=CH), 3.13
(m, 1H, CHCH=CH), 2.44 (m, 1H, CHCH=CH), 2.42 (dd, J = 4.8, 3.9 Hz, 1H, CHCO), 2.10 (s,
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3H, CH3CO), 1.86 (m, 1H, CHCH3), 1.57 (m, 1H, C(H)H), 1.43 (m, 1H, C(H)H), 1.14 (d, J =
6.9 Hz, 3H, CHCH3); 13C NMR (75 MHz, CDCl3) δ 209.2, 138.8, 132.6, 61.9, 49.3, 46.6, 46.5,
35.9, 29.5, 21.4; HRMS (CI) exact mass calc’d for (C10H14O) requires m/z 150.1045, found m/z
150.1041. [α]D = + 70.4 (c = 1.0, CHCl3).  Product ratios were determined by GLC analysis (120
°C, 23 psi); (1R, 2R, 3S, 4R) endo isomer tr = 6.9 min, and (1S, 2S, 3R, 4S) endo isomer tr = 6.3
min, exo isomers tr = 5.7, 5.5 min.
1-[(1R , 2R , 3S, 4R)-3-Methylbicyclo[2.2.1]hept-5-en-2-yl]-propan-1-one (Table 2,
entry 2).  Prepared according to general procedure A from 4-hexen-3-one (70 µL, 0.61 mmol),
cyclopentadiene (75 µL, 0.91 mmol), 70% aqueous perchloric acid (10.5 µL, 0.12 mmol) and
(2S, 5S)-5-Benzyl-3-methyl-2-(5-methyl-furan-2-yl)-imidazolidin-4-one (30.7 mg, 0.12 mmol) in
water (203 µL) for 22 hours at 0 °C.  Purification by silica gel chromatography (9:1
pentane:ether) provided the title compound as a colorless oil in 89% yield (88.7 mg, 0.54 mmol);
25:1 endo:exo, endo 90% ee.  Product ratios were determined by GLC analysis (150 °C, 23 psi);
(1R, 2R, 3S, 4R) endo isomer tr = 3.7 min, and (1S, 2S, 3R, 4S) endo isomer tr = 3.6 min, exo
isomers tr = 3.4, 3.5 min.  H NMR, 13C NMR, and IR data 1were consistent with previously
reported values.13  [α]D = + 101.7 (c = 1.0, CHCl3).
Determination of the absolute stereochemistry of 1-[(1R , 2R , 3S, 4R)-3-
methylbicyclo[2.2.1]hept-5-en-2-yl]-propan-1-one by chemical correlation to (1R , 2R , 3S,
4R)-3-methylbicyclo[2.2.1]hex-5-ene-2-carboxaldehyde. ( 1R,  2R ,  3S , 4R )-3-
Methylbicyclo[2.2.1]hex-5-ene-2-carboxaldehyde14 was treated with ethylmagnesium chloride
followed by tetrapropylammonium perruthenate and 4-methylmorpholine N-oxide to afford 1-
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[(1R, 2R, 3S, 4R)-3-methylbicyclo[2.2.1]hept-5-en-2-yl]-propan-1-one; [α]D = + 105.5 (c = 1.0,
CHCl3).  The product was identical in all respects to the title compound.
1-[(1R , 2R , 3S , 4R)-3-Methylbicyclo[2.2.1]hept-5-en-2-yl]-pentan-1-one (Table 2,
entry 3).  Prepared according to general procedure A from oct-2-en-4-one (89 µL, 0.60 mmol),
cyclopentadiene (74 µL, 0.90 mmol), 70% aqueous perchloric acid (10.3 µL, 0.12 mmol) and
(2S , 5S)-5-benzyl-3-methyl-2-(5-methyl-furan-2-yl)-imidazolidin-4-one (32.4 mg, 0.12 mmol)
neat for 34 hours at 0 °C.  Purification by silica gel chromatography (19:1 hexanes:ethyl acetate)
provided the title compound as a colorless oil in 83% yield (95.7 mg, 0.50 mmol); 22:1 endo:exo,
endo 92% ee. IR (film) 3061, 2958, 2871, 1707, 1462, 1409, 1375, 1332, 1267, 1137, 1045,
904.4, 801.4, 715.9 cm-1; 1H NMR (300 MHz, CDCl3) δ 6.19 (dd, J = 5.4, 3.0 Hz, 1H, CH=CH),
5.87 (dd, J = 5.7, 2.7 Hz, 1H, CH=CH), 3.10 (br s, 1H, CHCH=CH), 2.43 (m, 1H, CHCH=CH),
2.39 (m, 3H, CHCO and CH2CO), 1.86 (m, 1H, CHCH3), 1.57-1.20 (m, 6H, COCH2CH2CH2,
and CHCH2CH), 1.12 (d, J = 6.9 Hz, 3H, CHCH3), 0.87 (dd, J = 7.5, 7.5 Hz, 3H, CH2CH3); 13C
NMR (75 MHz, CDCl3) δ 211.3, 138.6, 132.6, 61.2, 49.3, 46.6, 41.7, 35.9, 26.2, 22.8, 21.4, 14.3;
HRMS (CI) exact mass calc’d for (C13H20O) requires m/z 192.1514, found m/z 192.1509. [α]D =
+ 89.3 (c = 1.0, CHCl3).  Product ratios were determined by GLC analysis (150 °C, 23 psi); (1R,
2R, 3S, 4R) endo isomer tr = 6.1 min, and (1S, 2S, 3R, 4S) endo isomer tr = 5.9 min, exo isomers
tr = 5.5, 5.6 min.
Determination of the absolute stereochemistry of 1-[(1R , 2R , 3S, 4R)-3-
methylbicyclo[2.2.1]hept-5-en-2-yl]-pentan-1-one by correlation from (1R, 2R, 3S, 4R)-3-
methylbicyclo[2.2.1]hex-5-ene-2-carboxaldehyde. ( 1R,  2R,  3 S ,  4R)-3-
Methylbicyclo[2.2.1]hex-5-ene-2-carboxaldehyde15 was treated with n-butyllithium followed by
tetrapropylammonium perruthenate and 4-methylmorpholine N-oxide to afford 1-[(1R, 2R, 3S,
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4R)-3-methylbicyclo[2.2.1]hept-5-en-2-yl]-pentan-1-one; [α]D = + 87.4 (c = 1.0, CHCl3).  The
product was identical in all respects to the title compound.
4-Methyl-1-[(1R , 2R , 3S, 4R)-3-methylbicyclo[2.2.1]hept-5-en-2-yl]-pentan-1-one
(Table 2, entry 4).  Prepared according to general procedure A from 7-methyloct-2-en-4-one (82
µL, 0.50 mmol), cyclopentadiene (62 µL, 0.75 mmol), 70% aqueous perchloric acid (8.6 µL,
0.10 mmol) and (2S, 5S)-5-benzyl-3-methyl-2-(5-methyl-furan-2-yl)-imidazolidin-4-one (27 mg,
0.10 mmol) in water (167 µL) for 38 hours at 0 °C.  Purification by silica gel chromatography
(19:1 hexanes:ethyl acetate) provided the title compound as a colorless oil in 86% yield (89 mg,
0.43 mmol); 20:1 endo:exo, endo 92% ee. IR (film) 3061, 2957, 2870, 1708, 1462, 1367, 1332,
1269, 1141, 1107, 1064, 904.7, 799.8, 716.2 cm-1; 1H NMR (300 MHz, CDCl3) δ 6.20 (dd, J =
5.7, 3.0 Hz, 1H, CH=CH), 5.87 (dd, J = 5.7, 2.7 Hz, 1H, CH=CH), 3.11 (m, 1H, CHCH=CH),
2.43 (m, 1H, CHCH=CH), 2.39 (m, 3H, CHCO and CH2CO), 1.86 (m, 1H, CHCH3), 1.58-1.37
(m, 5H, COCH2CH2CH, CHCH2CH), 1.13 (d, J = 6.9 Hz, 3H, CH2CH3), 0.86 (d, J = 6.3 Hz, 6H,
CH(CH3)2); 13C NMR (75 MHz, CDCl3) δ 211.5, 138.6, 132.6, 61.2, 49.3, 46.6, 40.0, 35.9, 32.9,
28.1, 22.8, 22.7, 21.4; HRMS (CI) exact mass calc’d for (C14H22O) requires m/z 206.1671, found
m/z 206.1671. [α]D = + 89.4 (c = 1.0, CHCl3).  Product ratios were determined by GLC analysis
(150 °C, 23 psi); (1R, 2R, 3S, 4R) endo isomer tr = 7.4 min, and (1S, 2S, 3R, 4S) endo isomer tr =
7.1 min, exo isomers tr = 6.6, 6.8 min.
Determination of the absolute stereochemistry of 4-methyl-1-[(1R , 2R , 3S, 4R)-3-
methylbicyclo[2.2.1]hept-5-en-2-yl]-pentan-1-one by correlation with (1R, 2R, 3S, 4R)-3-
methylbicyclo[2.2.1]hex-5-ene-2-carboxaldehyde. ( 1R,  2R,  3 S ,  4R)-3-
Methylbicyclo[2.2.1]hex-5-ene-2-carboxaldehyde1 5 was treated with (3-methyl-butyl)-
magnesiumbromide followed by tetrapropylammonium perruthenate and 4-methylmorpholine N-
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oxide to afford 4-methyl-1-[(1R, 2R , 3S, 4R)-3-methylbicyclo[2.2.1]hept-5-en-2-yl]-pentan-1-
one ; [α]D = + 81.2 (c = 1.0, CHCl3).  The product was identical in all respects to the title
compound.
2-Methyl-1-[3-methylbicyclo[2.2.1]hept-5-en-2-yl]-propan-1-one (Table 2, entry 5).
Prepared according to general procedure A from 2-methylhex-4-en-3-one (66 µL, 0.50 mmol),
cyclopentadiene (62 µL, 0.75 mmol), 70% aqueous perchloric acid (8.6 µL, 0.10 mmol) and (2S,
5S)-5-benzyl-3-methyl-2-(5-methyl-furan-2-yl)-imidazolidin-4-one (27 mg, 0.10 mmol) in water
(125 µL) for 48 hours at 0 °C.  Purification by silica gel chromatography (9:1 pentane:ether)
provided the title compound as a colorless oil in 24% yield (22 mg, 0.12 mmol) as well as 29 mg
recovered 2-methyl-hex-4-en-3-one; 8:1 endo:exo, endo 0% ee. IR (film) 3062, 2965, 2872,
1707, 1573, 1464, 1381, 1364, 1333, 1264, 1224, 1177, 1129, 1102, 1043, 1009, 908.1, 801.7,
724.5. 694.3 cm-1; 1H NMR (300 MHz, CDCl3) δ 6.23 (dd, J = 6.0, 3.3 Hz, 1H, CH=CH), 5.84
(dd, J = 6.0, 2.7 Hz, 1H, CH=CH), 3.10 (m, 1H, CHCH=CH), 2.73 (dq, 1H, CH(CH3)2), 2.61
(dd, J = 4.5, 3.3, 1H, CHCO), 2.46 (m, 1H, CHCH=CH), 1.87 (ddq, J = 6.6, 1.8, 1.8 Hz, 1H,
CHCHCO), 1.59 (m, 1H, one of CH2), 1.44 (m, 1H, one of CH2), 1.13 (d, J = 7.2 Hz, 3H,
CH3CHCHCO), 1.07 (d, J = 7.2 Hz, 3H, one of (CH3)2CH), 1.03 (d, J = 6.9 Hz, 3H, one of
(CH3)2CH); 13C NMR (75 MHz, CDCl3) δ 215.3, 138.6, 132.5, 59.2, 49.4, 46.9, 46.8, 39.7, 35.9,
21.3, 19.4, 18.7; HRMS (CI) exact mass calc’d for (C12H18O) requires m/z 178.1358, found m/z
178.1356. [α]D = 0.0 (c = 1.0, CHCl3).  Product ratios were determined by GLC analysis (150 °C,
23 psi); endo isomers tr = 3.8 min, 3.7 min, exo isomers tr = 3.6, 3.5 min.
1-[(1R , 2R , 3S , 4R)-3-Propylbicyclo[2.2.1]hept-5-en-2-yl]-propan-1-one (Table 2,
entry 6).  Prepared according to general procedure A from oct-4-en-3-one (112 µL, 0.75 mmol),
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cyclopentadiene (93 µL, 1.13 mmol), 70% aqueous perchloric acid (12.9 µL, 0.15 mmol) and
(2S, 5S)-5-benzyl-3-methyl-2-(5-methyl-furan-2-yl)-imidazolidin-4-one (40.5 mg, 0.15 mmol) in
water (150 µL) for 32 hours at 0 °C.  Purification by silica gel chromatography (15:1
pentane:ether) provided the title compound as a colorless oil in 84% yield (120 mg, 0.62 mmol);
15:1 endo:exo, endo 92% ee.  IR (film) 3060, 2961, 2872, 1710, 1459, 1413, 1377, 1333, 1216,
1106, 1017, 935.7, 904.3, 716.7 cm-1; 1H NMR (300 MHz, CDCl3) δ 6.22 (dd, J = 6.0, 3.3 Hz,
1H, CH=CH), 5.84 (dd, J = 5.4, 2.7 Hz, 1H, CH=CH), 3.12 (m, 1H, CHCH=CH), 2.57 (m, 1H,
CHCH=CH), 2.45 (m, 3H, CH2CO and CHCO), 1.83 (m, 1H, CH(nPr)), 1.59-1.19 (br m, 6H,
CH3CH2CH2, and CHCH2CH), 1.02 (dd, J = 6.0, 6.0 Hz, 3H, CH3), 0.89 (dd, J = 7.2, 7.2 Hz, 3H,
CH3); 13C NMR (75 MHz, CDCl3) δ 211.7, 138.8, 132.4, 59.5, 47.3, 47.2, 46.6, 41.4, 38.7, 35.1,
22.3, 14.7, 8.3; HRMS (CI) exact mass calc’d for (C13H20O) requires m/z 192.1514, found m/z
192.1512. [α]D = + 91.5 (c = 1.0, CHCl3).  Product ratios were determined by GLC analysis (150
°C, 23 psi); (1R, 2R, 3S, 4R) endo isomer tr = 6.0 min, and (1S, 2S, 3R, 4S) endo isomer tr = 5.6
min, exo isomers tr = 5.1, 5.4 min.
1-[(1R, 2R, 3S, 4R)-3-Isopropylbicyclo[2.2.1]hept-5-en-2-yl]-propan-1-one (Table 2,
entry 7).  Prepared according to general procedure A from 6-methylhept-4-en-3-one (89 µL,
0.60 mmol), cyclopentadiene (99 µL, 1.2 mmol), 70% aqueous perchloric acid (10.3 µL, 0.12
mmol) and (2S, 5S)-5-benzyl-3-methyl-2-(5-methyl-furan-2-yl)-imidazolidin-4-one (32 mg, 0.12
mmol) in water (120 µL) for 2.5 days at 0 °C.  Then, an additional 1.2 mmol of cyclopentadiene
was added and the mixture was allowed to stir for an additional 3.5 days at 0 °C.  Purification by
silica gel chromatography (18:1 pentane:ether) provided the title compound as a colorless oil in
78% yield (90 mg, 0.47 mmol); 6:1 endo:exo, endo 90% ee.  For the purpose of characterization,
the more quickly eluting exo diastereomer was removed by silica gel chromatography as above.
IR (film) 3057, 2961, 2869, 1709, 1460, 1367, 1334, 1136, 1028, 904.2, 716.6 cm-1; 1H NMR
(300 MHz, CDCl3) δ 6.26 (dd, J = 5.7, 3.3 Hz, 1H, CH=CH), 5.79 (dd, J = 5.7, 2.7 Hz, 1H,
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CH=CH), 3.14 (m, 1H, CHCH=CH), 2.77 (m, 1H, CHCH=CH), 2.63 (dd, J = 3.6, 3.6 Hz, 1H,
CHCO), 2.49 (m, 2H, CH2CO), 1.40 (m, 3H, CH(CH3)2 and CHCH2CH), 1.05 (d, J = 7.5 Hz,
3H, one of CH(CH3)2), 0.99 (dd, J = 4.8, 4.8 Hz,  3H, CH2CH3), 0.84 (d, J = 7.5 Hz, 3H, one of
CH(CH3)2); 13C NMR (75 MHz, CDCl3) δ 211.6, 139.6, 131.9, 57.8, 49.1, 47.4, 47.2, 45.5, 35.2,
33.1, 22.7, 22.2, 8.5; HRMS (CI) exact mass calc’d for (C13H20O) requires m/z 192.1514, found
m/z 192.1513. [α]D = + 20.1 (c = 1.0, CHCl3).  Product ratios were determined by GLC analysis
(162 °C, 23 psi); (1R, 2R, 3S, 4R) endo isomer tr = 4.4 min, and (1S, 2S, 3R, 4S) endo isomer tr =
4.2 min, exo isomers tr = 3.9, 4.1 min.
1-[(1R, 2S)-2-Methoxycyclohex-3-en-1-yl]-propan-1-one (Table 3, entry 1).  Prepared
according to general procedure B from ethyl vinyl ketone (59 µL, 0.59 mmol), 1-
methoxybutadiene (75 µL, 0.74 mmol) added via syringe pump over 12 hours, 70% aqueous
perchloric acid (10.2 µL, 0.12 mmol) and (2S, 5S)-5-benzyl-3-methyl-2-(5-methyl-furan-2-yl)-
imidazolidin-4-one (32 mg, 0.12 mmol) in ethanol (590 µL) for 3.5 days at –30 °C.  Purification
by silica gel chromatography (9:1 pentane:ether) provided the title compound as a single
diastereomer (as judged by GLC analysis) in 88% yield (88 mg, 0.52 mmol) and 92% ee.  IR
(film) 3027, 2975, 2937, 2879, 2821, 1715, 1452, 1432, 1375, 1211, 1191, 1129, 1108, 1084,
917.8, 889.2 cm-1; 1H NMR (300 MHz, CDCl3) δ  5.95 (m, 2H, CH=CH), 4.06 (m, 1H,
CHOCH3), 3.30 (s, 1H, OCH3), 2.53 (m, 3H, CH2CO and CHCO), 2.20 (m, 1H, one of
CH2CH=CH), 1.85 (m, 3H, CH2CHCOEt and one of C(H)HCH=CH), 1.05 (dd, J = 7.2, 7.2 Hz,
3H, CH2CH3); 13C NMR (75 MHz, CDCl3) δ 211.5, 133.2, 124.5, 73.0, 56.7, 51.8, 33.8, 25.6,
18.7, 8.1; HRMS (CI) exact mass calc’d for [M – CH3OH]+ (C9H12O0) requires m/z 136.0888,
found m/z 136.0889. [α]D = + 16.7 (c = 1.0, CHCl3).  Product ratios were determined by GLC
analysis (100 °C, 23 psi); (1R, 2S) endo isomer tr = 29.6 min, and (1S, 2R) endo isomer tr = 32.6
min, exo isomers tr = 19.1, 19.4 min.
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Benzyl  (1S, 6R)-6-propionylcyclohex-2-en-1-ylcarbamate (Table 3, entry 2).
Concentrated (70% aqueous) perchloric acid (431 µL, 5.0 mmol) was added slowly to a stirring
solution of ethyl vinyl ketone (2.49 mL, 25.0 mmol) and (2S , 5S)-5-benzyl-3-methyl-2-(5-
methyl-furan-2-yl)-imidazolidin-4-one (1.35 g, 5.0 mmol) pre-chilled to –30 °C.  Then, buta-1,3-
dienyl-carbamic acid benzyl ester (4.47g, 31.3 mmol) was added dropwise over 15 minutes as a
solution in 12.5 mL of absolute ethanol.  After stirring for 3.5 days, the reaction was diluted with
ether (150 mL), washed successively with 1N HCl (50 mL), water (50 mL) and brine (25 mL).
The organic layer was then dried over anhydrous magnesium sulfate, filtered and concentrated in
vacuo to afford a pale brown oil.  Purification by silica gel (8:1 hexanes:ethyl acetate) afforded
the title compound as a single diastereomer (as judged by HPLC analysis) in 91% yield (5.17g,
22.7 mmol) and 98% ee.  The combined aqueous extracts were treated with solid K2CO3,
extracted with 3 x 50 mL portions of CHCl3, dried over anhydrous Na2SO4 and concentrated in
vacuo  to afford a 91% recovery of (2S, 5S)-5-benzyl-3-methyl-2-(5-methyl-furan-2-yl)-
imidazolidin-4-one (1.23 g, 4.55 mmol) after silica gel chromatography.  IR (film) 3411, 3329,
3064, 3031, 2974, 2938, 2879, 2836, 1956, 1872, 1711, 1523, 1455, 1409, 1376, 1331, 1278,
1236, 1164, 1120, 1060, 1028, 988.9, 973.1, 775.6, 736.0, 697.9 cm-1; 1H NMR (300 MHz,
CDCl3) δ  7.33 (m, 5H, ArH), 5.82 (m, 1H, CH=CH), 5.70 (m, 1H, CH=CH), 5.04 (m, 3H,
CH2Ph and NH), 4.63 (m, 1H, CHNH), 2.86 (ddd, J = 10.2, 3.9, 3.9 Hz, 1H, CHCO), 2.70 (dq, J
= 18.0, 7.2 Hz, 1H, one of CH2CO), 2.43 (dq, J = 17.7, 7.2 Hz, 1H, one of CH2CO), 2.10-1.65
(m, 4H, CH2CH2), 1.00 (dd, J = 6.9, 6.9 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 212.0,
155.9, 136.6, 130.1, 128.7, 128.2, 128.1, 126.9, 67.0, 50.4, 46.9, 34.8, 24.2, 20.7, 8.0; HRMS
(CI) exact mass calc’d for (C17H21NO3) requires m/z 287.1521, found m/z 287.1519. [α]D = +
122.0 (c = 1.0, CHCl3).  Product ratios were determined by HPLC analysis (OD-H column, 3%
ethanol in hexanes, 1 mL/min, 254 nm); (1S, 6R) endo isomer tr = 12.5 min, and (1R, 6S) endo
isomer tr = 11.3 min, exo isomers tr = 8.6, 9.2 min.
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1-[(1R)-4-Phenylcyclohex-3-en-1-yl]-propan-1-one (Table 3, entry 3).  Prepared
according to general procedure B from ethyl vinyl ketone (48 µL, 0.48 mmol), 1-(methylene-
allyl)-benzene (83 µL, 0.60 mmol), 70% aqueous perchloric acid (8.2 µL, 0.10 mmol), (2 S, 5S)-
5-benzyl-3-methyl-2-(5-methyl-furan-2-yl)-imidazolidin-4-one (26 mg, 0.10 mmol), and 14.4
mg of anhydrous calcium chloride (as dessicant) in ethanol (160 µL) for 4 days and 10 hours at
–40 °C.  Purification by silica gel chromatography (9:1 pentane:ether) provided the title
compound as a single regioisomer (as judged by GLC analysis) in 92% yield (94 mg, 0.44 mmol)
and 90% ee.  IR (film) 3030, 2975, 2935, 2838, 1975, 1879, 1809, 1709, 1598, 1495, 1444, 1410,
1376, 1343, 1213, 1126, 1061, 1020, 958.4, 918.1, 868.1, 806.5, 743.2, 694.8 cm-1; 1H NMR
(300 MHz, CDCl3) δ 7.35 (m, 5H, ArH), 6.12 (m, 1H, C=CH), 2.54 (m, 7H, CH2CO, CHCO,
CH2CH, and allylic CH2CH2), 2.12 (m, 1H, C(H)H), 1.73 (m, 1H, C(H)H), 1.08 (dd, J = 7.2, 7.2
Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 214.2, 141.9, 136.4, 128.5, 127.1, 125.2, 123.0,
46.4, 34.4, 28.2, 27.5, 25.7, 8.2; HRMS (CI) exact mass calc’d for (C15H18O) requires m/z
214.1358, found m/z 214.1356. [α]D = + 67.2 (c = 1.0, CHCl3).  Product ratios were determined
by GLC analysis (150 °C, 23 psi); (R) isomer tr = 62.4 min, and (S) isomer tr = 60.8 min,
regioisomers tr = 49.6, 50.2 min.
1-[(1R , 2S)-2,4-Dimethylcyclohex-3-en-1-yl]-propan-1-one (Table 3, entry 4).
Prepared according to general procedure B from ethyl vinyl ketone (59 µL, 0.59 mmol), trans-2-
methyl-1,3-pentadiene (94 µL, 0.89 mmol), 70% aqueous perchloric acid (10.2 µL, 0.12 mmol)
and (2S, 5S)-5-benzyl-3-methyl-2-(5-methyl-furan-2-yl)-imidazolidin-4-one (32 mg, 0.12 mmol)
in ethanol (590 µL) for 4.5 days at –30 °C.  Purification by silica gel chromatography (9:1
pentane:ether) provided the title compound as a single diastereomer (as judged by GLC analysis)
in 90% yield (90 mg, 0.54 mmol) and 90% ee.  IR (film) 2964, 2937, 2874, 2833, 1711, 1452,
1377, 1343, 1227, 1195, 1123, 1038, 984.2, 886.0, 841.6 cm-1; 1H NMR (300 MHz, CDCl3) δ
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5.37 (m, 1H, CH=CCH3), 2.60 (m, 2H, CHCO and CHCH3), 2.50 (dq, J = 17.4, 7.5 Hz, 1H,
C(H)HCO), 2.37 (dq, J = 17.4, 7.5 Hz, 1H, C(H)HCO), 1.94 (m, 2H, =CCH2), 1.68 (m, 2H,
CH2CH), 1.64 (s, 3H, CH3C=CH), 1.05 (dd, J = 7.5, 7.5 Hz, 3H, CH2CH3), 0.76 (dd, J = 6.9, 6.9
Hz, 3H, CH3CH); 13C NMR (75 MHz, CDCl3) δ 214.0, 133.7, 126.3, 50.5, 34.6, 31.7, 30.2, 23.8,
19.0, 16.8, 8.1. [α]D = + 16.7 (c = 1.0, CHCl3).  Product ratios were determined by GLC analysis
(100 °C, 23 psi); (1R, 2S) endo isomer tr = 21.3 min, and (1S, 2R) endo isomer tr = 20.4 min, exo
isomers tr = 15.4, 16.6 min.
1-[(1R)-4-Methylcyclohex-3-en-1-yl]-propan-1-one (Table 3, entry 5).  Prepared
according to general procedure B from ethyl vinyl ketone (70 µL, 0.70 mmol), isoprene (140 µL,
1.40 mmol), 70% aqueous perchloric acid (12.1 µL, 0.14 mmol) and (2S, 5S)-5-benzyl-3-methyl-
2-(5-methyl-furan-2-yl)-imidazolidin-4-one (38 mg, 0.14 mmol) neat for 3 days at –20 °C.
Then, another portion of isoprene (100 µL, 1.00 mmol) was added and the solution was allowed
to stir for an additional 3 days.  Purification by silica gel chromatography (10:1 pentane:ether)
provided the title compound as a single regioisomer (as judged by GLC analysis) in 79% yield
(84 mg, 0.55 mmol) and 85% ee.  IR (film) 2967, 2928, 2836, 1710, 1452, 1413, 1377, 1343,
1217, 1149, 1126, 952.6, 915.1, 871.9, 800.0 cm-1; 1H NMR (300 MHz, CDCl3) δ 5.34 (m, 1H,
C=CH), 2.46 (m, 3H, CH2CO and CHCO), 2.09 (m, 2H, CH2CH=C(CH3)), 1.94 (m, 2H,
CH2C(CH3)=CH), 1.86 (m, 1H, one of CH2CH2CH), 1.54 (m, 1H, one of CH2CH2CH), 0.99 (dd,
J = 7.5, 7.5 Hz, 3H, CH2CH3); 13C NMR (75 MHz, CDCl3) δ 214.4, 133.8, 119.6, 46.6, 34.1,
29.9, 27.6, 25.4, 23.7, 8.1; HRMS (CI) exact mass calc’d for (C10H16O) requires m/z 152.1201,
found m/z 152.1201. [α]D = + 37.8 (c = 1.0, CHCl3).  Product ratios were determined by GLC
analysis (100 °C, 23 psi); (R) isomer tr = 16.1 min, and (S) isomer tr = 15.4 min.
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Determination of the absolute stereochemistry of 1-[(1R)-4-methylcyclohex-3-en-1-
yl]-propan-1-one by correlation from (1R)-4-methyl-3-cyclohexene-1-carboxaldehyde. (1R)-
4-Methyl-3-cyclohexene-1-carboxaldehyde15 was treated with ethylmagnesium bromide
followed by tetrapropylammonium perruthenate and 4-methylmorpholine N-oxide to afford 1-
[(1R)-4-methylcyclohex-3-en-1-yl]-propan-1-one; [α]D = + 41.3 (c = 1.0, CHCl3).  The product
was identical in all respects to the title compound.
(1R, 2R, 6R, 7R)-Tricyclo[5.2.1.0~2,6~]dec-8-en-3-one (Table 4, entry 1).  Prepared
according to general procedure A from 2-cyclopenten-1-one (50 µL, 0.60 mmol),
cyclopentadiene (74 µL, 0.90 mmol), 70% aqueous perchloric acid (10.3 µL, 0.12 mmol) and
(2S, 5S)-5-benzyl-3-methyl-2-(5-methyl-furan-2-yl)-imidazolidin-4-one (32.4 mg, 0.12 mmol) in
water (150 µL) for 12 hours at 0 °C.  Purification by silica gel chromatography (5:1
pentane:ether) provided the title compound as a volatile white powder in 81% yield (72 mg, 0.49
mmol); 15:1 endo:exo, endo 48% ee.  IR (film) 3058, 2964, 2941, 2868, 1730, 1475, 1402, 1341,
1318, 1225, 1172, 1129, 1090, 1040, 936.0, 902.3, 840.8, 804.2, 732.8 cm-1; 1H NMR (300 MHz,
CDCl3) δ 6.22 (dd, J = 5.7, 2.7 Hz, 1H, CH=CH), 6.11 (dd, J = 5.7, 3.0 Hz, 1H, CH=CH), 3.19
(m, 1H, CHCH=CH), 3.00 (m, 1H, CHCH=CH), 2.97 (m, 1H, CHCO), 2.85 (m, 1H,
C(H)HCO), 2.02 (m, 4H, CHCH2CH2, C(H)HCO, and CHCH2CH), 1.48 (m, 2H, CH2CH2CO);
13C NMR (75 MHz, CDCl3) δ 222.6, 136.3, 135.0, 54.7, 52.6, 47.8, 47.4, 41.6, 40.9, 23.1; HRMS
(CI) exact mass calc’d for (C10H12O) requires m/z 148.0888, found m/z 148.0887. [α]D = + 122.3
(c = 1.0, CHCl3).  Product ratios were determined by GLC analysis (140 °C, 23 psi); (1R, 2R, 6R,
7R) endo isomer tr = 7.1 min, and (1S, 2S, 6S, 7S) endo isomer tr = 6.7 min, exo isomers tr = 6.1
min.
(1R, 2R, 7R, 8R)-Tricyclo[6.2.1.0~2,7~]undec-9-en-3-one (Table 4, entry 2).  Prepared
according to general procedure A from 2-cyclohexen-1-one (58 µL, 0.60 mmol),
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cyclopentadiene (74 µL, 0.90 mmol), 70% aqueous perchloric acid (10.3 µL, 0.12 mmol), and
(2S, 5S)-5-benzyl-3-methyl-2-(5-methyl-furan-2-yl)-imidazolidin-4-one (32.4 mg, 0.15 mmol) in
water (150 µL) for 17 hours at 0 °C.  Purification by silica gel chromatography (5:1
pentane:ether) provided the title compound as a colorless oil in 81% yield (79 mg, 0.49 mmol);
12:1 endo:exo, endo 63% ee.  For the purposes of characterization, the endo isomer was
separated from the exo isomer by silica gel chromatography.  IR (film) 3061, 2961, 2935, 2867,
1701, 1570, 1453, 1406, 1358, 1337, 1315, 1236, 1172, 1115, 1018, 910.6, 823.8, 779.2, 733.6,
561.5 cm-1; 1H NMR (300 MHz, CDCl3) δ 6.15 (dd, J = 5.7, 3.0 Hz, 1H, CH=CH), 5.99 (dd, J =
5.7, 3.0 Hz, 1H, CH=CH), 3.24 (m, 1H, CHCH=CH), 2.85 (m, 1H, CHCH=CH), 2.66 (m, 2H,
CH(H)CO and CHCO), 2.30 (m, 1H, one of CH2CO), 1.79 (m, 4H, CHCHCH2, COCH2CH2 and
one of CHCHCH2), 1.42 (ddd, J = 8.4, 1.8, 1.8 Hz, 1H, one of CHCH2CH), 1.28 (m, 1H, one of
CHCH2CH), 0.73 (m, 1H, one of CHCHCH2); 13C NMR (75 MHz, CDCl3) δ 215.7, 137.8, 135.1,
52.0, 48.7, 46.8, 45.5, 41.7, 39.7, 28.4, 22.2; HRMS (CI) exact mass calc’d for (C11H14O)
requires m/z 162.1045, found m/z 162.1049. [α]D = + 120.6 (c = 1.0, CHCl3).  Product ratios
were determined by GLC analysis (130 °C, 23 psi); (1R, 2R, 7R, 8R) endo isomer tr = 13.4 min,
and (1S, 2S, 7S, 8S) endo isomer tr = 13.2 min, exo isomers tr = 11.7, 12.3 min.
(1R , 2R , 8R , 9R)-Tricyclo[7.2.1.0~2,6~]dodec-10-en-3-one (Table 4, entry 3).
Prepared according to general procedure A from 2-cyclohepten-1-one (67 µL, 0.60 mmol),
cyclopentadiene (74 µL, 1.13 mmol), 70% aqueous perchloric acid (10.2 µL, 0.12 mmol) and
(2S, 5S)-5-benzyl-3-methyl-2-(5-methyl-furan-2-yl)-imidazolidin-4-one (32.4 mg, 0.12 mmol) in
water (150 µL) for 28 hours at 0 °C.  Purification by silica gel chromatography (5:1
pentane:ether) provided the title compound as a colorless oil in 85% yield (90 mg, 0.51 mmol);
18:1 endo:exo, endo 90% ee.  IR (film) 2958, 2930, 2862, 1700, 1455, 1405, 1335, 1289, 1246,
1166, 1125, 1066, 949.6, 912.0, 860.4, 776.5, 722.9, 580.5, 554.0 cm-1; 1H NMR (300 MHz,
CDCl3) δ 6.39 (dd, J = 5.4, 2.7 Hz, 1H, CH=CH), 5.91 (dd, J = 5.4, 3.0 Hz, 1H, CH=CH), 3.17
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(dd, J = 10.2, 3.3 Hz, 1H, CHCO), 2.99 (m, 1H, CHCH=CH), 2.70 (m, 1H, CHCH=CH), 2.44
(m, 2H, CH2CO), 2.21 (m, 1H, CHCHCO), 1.96-1.28 (br m, 7H, CHCH2CH, COCH2CH2CH2,
and one of CHCHCH2), 0.74 (m, 1H, one of CHCHCH2); 13C NMR (75 MHz, CDCl3) δ 213.9,
137.7, 132.5, 58.6, 48.9, 48.1, 45.1, 43.0, 41.8, 30.8, 27.6, 23.2; HRMS (CI) exact mass calc’d
for (C12H16O) requires m/z 176.1201, found m/z 176.1201. [α]D = + 9.1 (c = 1.0, CHCl3).  Product
ratios were determined by GLC analysis (140 °C, 23 psi); (1R, 2R, 8R, 9R) endo isomer tr = 13.2
min, and (1S, 2S, 8S, 9S) endo isomer tr = 12.8 min, exo isomers tr = 11.8, 15.0 min.
(1R, 2R, 9R, 10R)-Tricyclo[8.2.1.0~2,6~]tridec-11-en-3-one (Table 4, entry 4).
Prepared according to general procedure A from 2-cycloocten-1-one (82 µL, 0.60 mmol),
cyclopentadiene (74 µL, 1.13 mmol), 70% aqueous perchloric acid (10.2 µL, 0.12 mmol) and
(2S, 5S)-5-benzyl-3-methyl-2-(5-methyl-furan-2-yl)-imidazolidin-4-one (32.4 mg, 0.12 mmol) in
water (240 µL) for 72 hours at 0 °C.  Purification by silica gel chromatography (19:1
pentane:ether) provided the title compound as a colorless oil in 83% yield (95 mg, 0.50 mmol);
6:1 endo:exo, endo 91% ee.  IR (film) 3060, 2928, 2856, 1701. 1454, 1338, 1290, 1222, 1175,
1073, 1019, 895.9, 838.2, 716.9 cm-1; 1H NMR (300 MHz, CDCl3) δ 6.49 (dd, J = 5.4, 2.7 Hz,
1H, CH=CH), 5.98 (dd, J = 5.4, 2.7 Hz, 1H, CH=CH), 3.29 (dd, J = 8.1, 3.3 Hz, 1H, CHCO),
2.90 (m, 1H, CHCH=CH), 2.72 (m, 1H, CHCH=CH), 2.49 (m, 2H, CH2CO), 2.15 (m, 1H,
CHCHCO), 1.82 (m, 2H, COCH2CH2), 1.63 (m, 1H, one of COCH2CH2C(H)H), 1.32 (m, 3H,
COCH2CH2C(H)H, and CHCH2CH2), 1.08 (m, 1H, CHC(H)H), 0.78 (m, 1H, , CHC(H)H); 13C
NMR (75 MHz, CDCl3) δ 215.9, 137.9, 132.0, 56.0, 50.9, 49.5, 48.3, 48.0, 47.4, 31.3, 30.9, 28.5,
23.6. [α]D = – 69.9 (c = 1.0, CHCl3).  Product ratios were determined by GLC analysis (150 °C,
23 psi); (1R, 2R, 9R, 10R) endo isomer tr = 12.8 min, and (1S, 2S, 9S, 10S) endo isomer tr = 12.4
min, exo isomers tr = 11.2, 10.6 min.
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(1R, 2R, 16S, 17R)-Tricyclo[15.2.1.0~2,16~]eicos-18-en-3-one (Table 4, entry 5).  Prepared
according to general procedure A from trans-2-cyclopentadecen-1-one (100 mg, 0.45 mmol),
cyclopentadiene (56 µL, 0.67 mmol), 70% aqueous perchloric acid (7.8 µL, 0.09 mmol) and (2S,
5S)-5-benzyl-3-methyl-2-(5-methyl-furan-2-yl)-imidazolidin-4-one (24.3 mg, 0.09 mmol) in
water (150 µL) for 72 hours at 0 o C.  Purification by flash chromatography (9:1 ethyl
acetate:hexanes) provided the title compound as a clear, colorless crystalline solid in 88% yield
(114 mg, 0.50 mmol); 5:1 endo:exo, endo 93% ee.  IR (film) 3052, 2922, 2854, 1698, 1456,
1368, 1331, 1225, 1126, 1084, 1016, 905.5, 884.9, 714.4 cm-1; 1H NMR (300 MHz, CDCl3) δ
6.21 (dd, J = 5.4, 2.7 Hz, 1H, CH=CH), 5.86 (dd, J = 5.4, 2.7 Hz, 1H, CH=CH), 3.09 (m, 1H,
CHCH=CH), 2.61 (m, 2H, CHCO and one of CH2CO), 2.52 (m, 1H, CHCH=CH), 2.41 (m, 1H,
one of CH2CO), 2.27 (m, 1H, CHCHCO), 1.81-1.24 (br m, 22H, (CH2)11); 13C NMR (75 MHz,
CDCl3) δ 211.6, 138.5, 132.6, 59.6, 48.4, 47.2, 46.7, 41.5, 41.3, 36.3, 28.0, 27.9, 27.7, 27.2, 26.8,
26.8, 26.7, 26.7, 26.0, 23.6. [α]D = + 22.2 (c = 1.0, CHCl3).  Product ratios were determined by
GLC analysis (200 °C, 23 psi); (1R, 2R, 16S, 17S) endo isomer tr = 20.1 min, and (1S, 2S, 16R,
17R) endo  isomer tr = 19.6 min, exo  isomers tr = 19.0, 18.6 min.  The t rans relative
stereochemistry of C-16 and C-17 was confirmed by the presence of an nOe between the C-16
methine proton and the two C-19 protons.
